Sort
30,917 grants matching “tumor microenvironment”
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$489,114Wei R. Chen · University Of Oklahoma · R01 · FY2025 · CA
The role of the senescent microenvironment on cancer initiating cells in the colon.
$489,084William M Grady · Fred Hutchinson Cancer Center · U01 · FY2023 · AG
The effect of oxygen gradients on sarcoma invasiveness through dynamic collagen modulation
$489,029Sharon Gerecht · Johns Hopkins University · U54 · FY2018 · CA
The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.
$489,027Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
$488,963Zihai Li · Cedars-Sinai Medical Center · P01 · FY2024 · CA
Molecular Imaging Guidance for Potentiating Chemoimmunotherapy in Pancreatic Cancer using Photodynamic Priming
$488,912Girgis Obaid · University Of Texas Dallas · R01 · FY2025 · EB
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2020 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2018 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2021 · CA
Salivary gland response to Desert hedgehog signaling as an antidote to damage from therapeutic radiation
$488,813Philip A Beachy · Stanford University · R01 · FY2024 · DE
Dissecting NF-kB pathway in HPV-associated head and neck cancer
$488,746Wendell G Yarbrough · Univ Of North Carolina Chapel Hill · R01 · FY2023 · DE
Regulation of Mast Cell Proteases
$488,644Richard L Stevens · Brigham And Women'S Hospital · P01 · FY2008 · HL
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis
$488,621Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
$488,578Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2023 · CA
GENETICALLY ENGINEERED T CELLS FOR DIPG
$488,517Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2024 · NS
Targeting the innate immune response in HNSCC
$488,418Judith A. Varner · University Of California, San Diego · R01 · FY2024 · DE
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
$488,414Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
$488,400Javeed Iqbal · University Of Nebraska Medical Center · R01 · FY2025 · CA
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$488,344Sidi A Bencherif · Northeastern University · R01 · FY2021 · EB
PD-1/PD-L1 modulation in cancer therapy
$488,332Drew M. Pardoll · Johns Hopkins University · R01 · FY2018 · CA
PD-1/PD-L1 modulation in cancer therapy
$488,332Drew M. Pardoll · Johns Hopkins University · R01 · FY2017 · CA
PD-1/PD-L1 modulation in cancer therapy
$488,332Drew M. Pardoll · Johns Hopkins University · R01 · FY2016 · CA
NIH Myeloid Malignancy Program
$488,202Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$488,090Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$488,090Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA